TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011

Phase I/II study of trastuzumab in combination with everolimus (RAD001) in patients with HER2-overexpressing metastatic breast cancer who progressed on trastuzumab-based therapy.

Phuong K Morrow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.